Login / Signup

Crizotinib response in a neuroblastoma patient with a constitutional mosaic anaplastic lymphoma kinase I1170N-activating mutation.

Melissa HarveyMeredith S IrwinLinlea ArmstrongKim SeathSean YoungSharon GershonyRebecca J Deyell
Published in: Pediatric blood & cancer (2021)
Keyphrases
  • diffuse large b cell lymphoma
  • case report
  • signaling pathway
  • advanced non small cell lung cancer
  • protein kinase
  • tyrosine kinase